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A B S T R A C T
Rheumatoid arthritis (RA) is one of the most destructive inflammatory and autoimmune joint diseases, most fre-
quently accompanied by extraarticular complications. The pathophysiologic mechanism and the importance of cell
subpopulations in the initiation and perpetuation of synovitis are not sufficiently understood. In this study the fre-
quency of lymphocyte subpopulations simultaneously in the synovial fluid (SF), the synovial membrane (SM) and pe-
ripheral blood (PB) of acute RA patients is determined, using flow cytometry procedures. The changes in the distribu-
tion of T lymphocyte subpopulations were significant on local levels in acute RA patients, resulting in a decreased
CD4/CD8 ratio in SF, but an increased CD4/CD8 ratio in SM, compared to the ratio found in PB. The differences ob-
served in the frequency of cells positive on natural killer (NK) cell markers suggest the role of CD16-CD56+ NK cell pop-
ulation in SF of RA patients. Significant differences in the observed frequency of lymphatic subpopulations suggest
certain specificities of local immunological events in SM and SF in acute RA. These results confirm the T-lymphocyte
hypothesis in initial pathogenic events in RA.
Key words: T lymphocytes, NK cells, peripheral blood, synovial fluid, synovial membrane, acute rheumatoid ar-
thritis
Introduction
Rheumatoid arthritis (RA) is an inflammatory dis-
ease with autoimmune features affecting synovial
joints. In severe cases there are extraarticular and sys-
temic complications. The basic aetiology of the disease is
not known, but aside for purely genetic predisposition,
there is abundant evidence suggesting the possibility
that activated lymphocytes might be central in the
pathogenic mechanism of joint destruction and extra-
articular complications in RA1–4. The pathogenetic role
of different lymphocyte sets and subsets has been inves-
tigated broadly in the peripheral blood (PB), the sy-
novial fluid (SF), and the synovial membrane (SM) of
RA patients, revealing significant oscillation in their
levels5–9. The question of which T cells contribute to the
pathogenetic changes in the early phase of the disease,
and which predominantly contribute to the perpetua-
tion of synovial inflammation in RA, remain unanswer-
ed. In addition, there are differences in T cell and NK
cell subsets depending on the phase of the disease and
the compartment analysed (systemic vs. local).
The purpose of this study is to determine the fre-
quency and distribution of lymphocyte subpopulations
simultaneously on local (synovial fluid and synovial
membrane) and systemic levels (peripheral blood) of
acute RA patients. The difference in the frequency of T
lymphatic subpopulations in different tissue compart-
ments in the acute stage of the disease suggests that ac-
tivated T lymphocytes play an important role in the ini-
tial pathogenic events in affected joints.
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Materials and Methods
Patient selection
This study was approved by The Ethics Committee of
the Medical Faculty, University of Rijeka, and was car-
ried out with the written consent of each subject. Pe-
ripheral blood and synovial tissue samples were ob-
tained from patients with acute rheumatoid arthritis.
All patients were hospitalized in the Clinic of Orthopae-
dic Surgery Lovran (Croatia). The diagnosis of RA was
based on the revised criteria of the American College of
Rheumatology (ACR) from 198710. Patients who met a
minimum of four out of seven possible criteria were
studied. The selection of rheumatic patients was based
solely on the availability of paired blood and synovial
tissue samples (synovial membrane and synovial fluid)
from patients undergoing synoviectomy or knee joint re-
placement surgery. Pregnant women, patients with im-
munological diseases or chronic diseases other than RA
(chronic pancreatitis, diabetes mellitus, haematopoetic
organ diseases etc.), and patients with malignant dis-
eases were excluded from the study. A combination of
clinical indicators (swollen and tender joints, skin hy-
perthermia) and results of laboratory testing (high ery-
throcyte sedimentation rate >30 mm/h, and high C-re-
active protein concentration in the blood serum) was
used to define the acute activity of the rheumatic articu-
lar disesase. The group of patients studied included
both patients in whom RA was diagnosed for the first
time and those already treated for RA, but hospitalized
in the acute stage of the disease. Patients were not di-
vided based on rheuma-factor seropositivity. Peripheral
blood, synovial membrane and synovial fluid samples
from 30 acute RA patients (21 female, 9 male, age range
37–60) were analysed. Synovial membrane and synovial
fluid samples were routinely obtained in the Clinic of
Orthopaedic Surgery Lovran, from patients undergoing
diagnostic or therapeutic joint tapping, arthroscopic
and open synoviectomy of the knee joint.
Preparation of synovial membrane lymphocytes
(SML)
Synovial membrane tissue free of blood coagulum
was rinsed several times in cold Rosswell Park Memo-
rial Institute (RPMI) 1640 medium (Institute of Immu-
nology, Zagreb), cut into small pieces and exposed to
trypsin digestion 0.125% trypsin, (Difco, Detroit, MI)
with 0.2% EDTA at 37°C for 90 minutes with constant
stirring. Trypsination was stopped by adding human AB
serum to the 10% concentration of solution. Cells thus
isolated were separated from the debris by passing
through nylon mesh twice and by undergoing centrifu-
gal sedimentation (600 g / 10 min). Supernatant was
then aspirated and 10 ml of RPMI 1640 was added to
the pellet. The cell suspension obtained was overlaid on
Ficoll/Hypaque (Pharmacia, Uppsala, Sweden), and
centrifuged at 800 g for 20 min. The cells accumulated
at the interface were collected, rinsed twice in the RPMI
1640 medium and cultured overnight in tissue culture
Petri dishes placed in a humidified CO2 incubator. After
macrophage adherence, the remaining mononuclear cell
suspension was aspirated and used for immunofluo-
rescent phenotyping. All samples were >95% viable, as
assessed by Trypan Blue dye exclusion. From the sy-
novial membrane of acute RA patients 6×105 to 6×106
MNC could be recovered, depending of the intensity of
MNC infiltration of synovial membrane samples and
the quantity of SM tissues obtained by diverse operative
procedures and subsequently subjected to flow cyto-
metric analysis.
Preparation of synovial fluid lymphocytes (SFL)
Synovial fluid (SF) was obtained from knee joints
and selected on the basis of SF volume obtained (a mini-
mum of 10 ml), due to mononuclear cell (MNC) require-
ments for flow cytometry (a minimum 1×106 MNC per
sample). Grossly hemorrhagic SF was not used. MNC
were collected after Ficoll-Hypaque density gradient
centrifugation, rinsed three times in the RPMI 1640
supplemented with 10% fetal calf serum (FCS). Further
steps were identical to those described for SML.
Preparation of peripheral blood lymphocytes
(PBL)
Approximately 20 ml of heparinized peripheral blood
was taken by cubital vein phlebotomy from patients un-
dergoing diagnostic or therapeutic procedures before
initiation of anaesthesia. Blood was overlaid onto Ficoll/
Hipaque, centrifuged for 20 min at 800 g, and MNC
from the interface were collected, rinsed, and cultured,
as described for SML.
Phenotypic detection of cell surface antigens
The phenotypic detection of cell surface membrane
antigens was performed by direct immunofluorescence
and analyzed by flow cytometry immediately after cell
separation. Briefly, cells were aliquoted (106 per aliquot)
and rinsed in FACS buffer (2% fetal calf serum (FCS), 1
mmol/L EDTA, 0.1% NaN3 in phosphate-buffered saline
(PBS), pH 7.4). Double labelling method of surface anti-
gens was used. The cells were simultaneously labeled
with monoclonal antibodies directly conjugated either
with FITC or PE fluoresecence dye (CD3-FITC, CD4-
PE, CD8-PE, CD16-PE, CD56-PE; Becton Dickinson,
Mountain View, CA) and the frequency of CD3+CD4+,
CD3+CD8+, CD3–CD16+ or CD3–CD56+ cells was esti-
mated, as well as the frequency of CD25+ lymphocytes.
Antibodies in the cell suspension were added in the con-
centration of 2 g/ 100 l at 4°C for 30 minutes. After
three rinses in the FACS medium, the cells were resus-
pended in the same volume of FACS medium. In all ex-
periments irrelevant isotype-matched murine mAbs
were used as a negative control. Viable lymphocytes
were gated on the basis of forward and side scatter (FSC
and SSC) profile. A minimum of 104 cells was analysed
on FACScan (Becton Dickinson), using Lysis II soft-
ware. The results of this analysis were shown in dot plot
graphs. The percentages of positive cells were obtained
by subtracting the values of the negative controls.
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Fig. 1. Flow cytometric analysis of the expression of CD3, CD4, CD8 and CD16 antigens on cell surface of (A) peripheral blood (PBL),
(B) synovial fluid (SFL), and (C) synovial membrane lymphocytes (SML) in patients with acute rheumatoid arthritis. The cells were
analysed on FACScan, using two-color cytometric analysis with fluorescein isothiocyanate- (CD3-FITC) or phycoerythrin-labeled
(CD4-PE, CD8-PE, CD16-PE) monoclonal antibodies. (a) The cells were first gated to include lymphocytes and a minimum of 104
cells were analysed for green (FITC, abscissa) and red (PE, ordinate) fluorescence. The frequency of CD3+CD4+ cells (b), CD3+CD8+
cells (c), and CD3–CD16+ (d) cells was estimated. The results shown are based on samples obtained from one representative acute
rheumatoid patient.
Statistical analysis
The obtained results were analysed using Sigma Plot
for Windows Version 1.02 (Jandel Scientific, Chicago,
IL). Statistical analyses were performed using a stan-
dard Student’s t-test one-way analysis for the compari-
son of means.
Results
Expression of cell surface antigens
In an attempt to define the immunoregulatory me-
chanims operating in rheumatoid arthritis we identified
the frequencies of total T lymphocytes (CD3 positive
cells), their subsets (CD3+CD4+ and CD3+CD8+ cells),
and NK cells (CD3–CD16+ and CD3–CD56+ cells), as
well as the number of activated cells bearing an IL-2 re-
ceptor (IL-2R+ or CD25+ cells) in acute RA patients
(systemic level), and compared them to the findings of
lymphocyte cell distribution in synovial membrane and
synovial fluid (local level). The comparative results of
statistical significance obtained from one representative
acute rheumatoid patient are shown in Figure 1.
The frequency of CD3 positive cells in PBL, SFL
and SML of acute RA patients
The frequencies of total T lymphocytes (CD3 positive
cells) in the samples of peripheral blood lymphocytes
(PBL), synovial fluid lymphocytes (SFL) and synovial
membrane lymphocytes (SML) of acute RA patients
were obtained by flow cytometry analysis. There was no
significant difference in the percentage of total T lym-
phocytes found on systemic and local levels in acute RA
patients (63–73%), which was presented in Figure 2.
The frequency of CD4 positive cells in PBL, SFL
and SML of acute RA patients
Analyzing the population of lymphocytes positive
both on CD3 and CD4 cell surface antigens (T helper cell
subset) in acute RA patients (Figure 3), we found that
their frequency was highest in the population of syno-
vial membrane lymphocytes (44%), and lowest in the
population of synovial fluid lymphocytes (25.8%). The
resulting difference in the distribution of CD4 positive
cells between the synovial fluid and peripheral blood
was statistically significant at the level where p<0.01,
and the difference in CD4 positive cell distribution in
the synovial membrane and the synovial fluid was sta-
tistically significant where p<0.001. Despite the fact
that higher values of CD4 positive cells were found in
the synovial membrane, compared to those in periph-
eral blood, the estimated difference was not statistically
significant.
The frequency of CD8 positive cells in PBL, SFL
and SML of acute RA patients
Immunophenotypic analysis of T lymphocytes posi-
tive both on CD3 and CD8 cell surface antigens (cyto-
toxic T lymphocytes), conducted on systemic and local
level in acute RA patients, revealed significant differ-
ences in autologous tissue compartments (Figure 4).
The highest percentage of these cells was found in the
population of synovial fluid lymphocytes (37.1%), and
statistically lower values were found in peripheral blood
(p<0.01) and the synovial membrane (p<0.001).
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Fig. 2. The percentages of CD3 positive lymphocytes in autolo-
gous samples (PBL, SFL, SML) obtained from 30 (21 female, 9
male) acute rheumatoid arthritis patients were estimated by flow
cytometry and all data sets were included in the statistical analy-
sis (X±SE). PBL – peripheral blood lymphocytes, SFL – synovial
fluid lymphocytes, SML – synovial membrane lymphocytes.
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Fig. 3. The percentages of CD4 positive lymphocytes in autolo-
gous samples (PBL, SFL, SML) obtained from 30 (21 female, 9
male) acute rheumatoid arthritis patients were estimated by
flow cytometry and all data sets were included in the statistical
analysis (X±SE). PBL – peripheral blood lymphocytes, SFL –
synovial fluid lymphocytes, SML – synovial membrane lympho-
cytes. Level of significance: ** p0.01, ***p0.001.
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Fig. 4. The percentages of CD8 positive lymphocytes in autolo-
gous samples (PBL, SFL, SML) obtained from 30 (21 female, 9
male) acute rheumatoid arthritis patients were estimated by flow
cytometry and all data sets were included in the statistical ana-
lysis (X±SE). PBL – peripheral blood lymphocytes, SFL – syno-
vial fluid lymphocytes, SML – synovial membrane lymphocytes.
Level of significance: ** p0.01, ***p0.001.
The ratio value of CD4 and CD8 positive
lymphocytes in different tissue compartments of
acute RA patients
In Figure 5 summarised percentages of CD3+CD4+
and CD3+CD8+ cells and CD3+CD4+/CD3+CD8+ (or CD4/
CD8) ratios in analysed tissue compartments (PBL,
SFL, SML) of acute RA patients are shown. In periph-
eral blood, the ratio of helper and cytotoxic lymphocyte
subpopulations was 1.5, which is in the normal range of
values for adults. In comparison to the same ratio in pe-
ripheral blood, the CD4/CD8 ratio was significantly
lower in synovial fluid (0.69), as a result of a simulta-
neous increase in CD8 and decrease in CD4 positive
cells in the synovial fluid of acute RA patients. In con-
trast, in the synovial membrane of acute RApatients we
found a higher CD4/CD8 ratio compared to that in pe-
ripheral blood (1.98).
The frequency of CD16 and CD56 positive cells
in PBL, SFL and SML of acute RA patients
Aiming to analyse NK cell involvement in acute RA
pathogenic processes, we estimated the expression of
cell surface antigens characteristic for this lymphocyte
population, CD16 (Figure 6) and CD56 (Figure 7), on
the CD3– lymphocyte subpopulation. In autologous sam-
ples of peripheral blood, synovial fluid and synovial
membrane lymphocytes of acute RA patients, signifi-
cant differences were found. The highest percentage of
CD16+ cells was obtained in the peripheral blood lym-
phocyte population (16.3%). A statistically lower per-
centage of these cells were found on a local level (syno-
vial membrane = 13%, p<0.01, synovial fluid 8.5%, p<
0.001). In contrast to the CD16 surface antigen, the
CD56 surface molecule was not expressed differently in
autologous tissue samples of acute RA patients. The re-
sulting higher frequency of CD56+ cells in peripheral
blood was not statistically significant in comparison to
that in the other two examined compartments.
The ratio value of CD16 and CD56 positive
lymphocytes in different tissue compartments of
acute RA patients
The percentage of CD3–CD16+ and CD3–CD56+ lym-
phocytes in different tissue compartments (PBL, SFL,
SML) in acute RA patients and their ratios are shown in
Figure 8. The CD3–CD16+ / CD3–CD56+ ratio (or CD16/
CD56 ratio) was identical (0.8) in peripheral blood and
the synovial membrane, but it was lower (0.5) in the
synovial fluid resulting from a significantly diminished
frequency of CD16+ cells in this joint compartment.
The frequency of CD25 positive cells in PBL, SFL
and SML of acute RA patients
The CD25 antigen or high affinity IL-2 receptor
(IL-2R) is prominent on activated T lymphocytes. The
distribution of this antigen among different tissue com-
partments in acute RA patients is shown in Figure 9. A
statistically significant difference in the level of expres-
sion of this antigen was found in different compart-
ments, with a higher level of manifestation found in pe-
ripheral blood lymphocyte populations than in the syno-
vial membrane populations (p<0.05).
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Fig. 5. The ratios of CD4 and CD8 positive lymphocytes in the
population of peripheral blood lymphocytes (PBL), synovial
fluid lymphocytes (SFL) and synovial membrane lymphocytes
(SML) obtained from 30 (21 female, 9 male) acute rheumatoid
arthritis patients.
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Fig. 6. The percentages of CD16 positive lymphocytes in auto-
logous samples (PBL, SFL, SML) obtained from 30 (21 female,
9 male) acute rheumatoid arthritis patients were estimated by
flow cytometry and all data sets were included in the statistical
analysis (X±SE). PBL – peripheral blood lymphocytes, SFL –
synovial fluid lymphocytes, SML – synovial membrane lympho-
cytes. Level of significance: ** p0.01, ***p0.001.
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Fig. 7. The percentages of CD56 positive lymphocytes in auto-
logous samples (PBL, SFL, SML) obtained from 30 (21 female, 9
male) acute rheumatoid arthritis patients were estimated by flow
cytometry and all data sets were included in the statistical analy-
sis (X±SE). PBL – peripheral blood lymphocytes, SFL – synovial
fluid lymphocytes, SML – synovial membrane lymphocytes.
Discussion
Rheumatoid arthritis (RA) is a chronic, systemic
imflammatory disease that affects approximately 1% of
the world population. Despite many years of intensive
study, neither the etiology, nor the pathogenic regula-
tory mechanisms of RA have been defined. Several
allelic variants of HLA-DRB1 genes (HLA DRB1*0401
and *0404) have been associated with RA, suggesting
that T-cell receptor HLA-antigen interactions play an
important role in the pathologic process in RA1–4. How-
ever, although a large body of data suggests that T lym-
phocytes play a crucial role in the pathogenic process,
there is much controversy regarding their role in and
contribution to the initiation and perpetuation of RA,
giving rise to both T-dependent and T-independent hy-
potheses regarding the pathogenesis of RA11–16. The
first hypothesis describes T lymphocytes as the main
initiative cell population which can be activated by a
certain, as yet undefined, specific exogenous antigen, or
that the autoreactive T lymphocytes in the joint can be
triggered by certain tissue antigens. The second hypoth-
esis proposes that the perpetuation of RA is not neces-
sarily an antigen-driven process and that T cells are
only one of several important factors in the perpetua-
tion of RA. Considerable uncertainty also remains re-
garding the frequency and distribution of distinct lym-
phocyte subpopulations in different tissue compart-
ments in acute RA patients, as well as regarding their
role in different stages of the disease11.
The importance of the T cell subpopulations in RA
was emphasized in our investigation as well. The re-
sults of the present study confirm certain previous find-
ings where the frequency of total T lymphocytes was
similar on both local and systemic levels in the acute
stage of RA. However, the percentages measured (70%)
in our study were close to the upper range of values
found in other investigations (30–70%).
To determine the potential role of T lymphocytes in
the initiation of RA, we analysed the distribution of dif-
ferent T lymphocyte subpopulations both on systemic
level (peripheral blood) and the local level (synovial
membrane and synovial fluid), where terminal joint de-
struction occurs. In spite of the fact that no difference
was detected in the level of CD3+ cells, significant chan-
ges were found in the CD4+ subpopulation of CD3+ cells
which, during the acute phase of RA, were the highest
in SM, where the pathologic process occurs. The associa-
tion of RAwith a class II MHC epitope implies that anti-
gen-specific responses of CD4+ T lymphocytes are re-
quired for the development of the disease16. Most stu-
dies identify this lymphocyte subpopulation as the most
important one in recognizing a potential arthritogenic
antigen present on specialized antigen presenting cells
(such as dendritic cells in SM). However, some longitu-
dinal studies suggest a negative corelation between the
number of CD4 synovial membrane lymphocytes and
the clinical intensity of the disease, suggesting in turn
the protective role of CD4+ lymphocytes17. Our results,
indicating an increased number of CD4+ T cells in the
synovial membrane in the initial stage of RA patients,
do not uphold this hypothesis. However, significantly
lower values of CD3+CD4+ cells were detected in the
synovial fluid, suggesting either that the CD4 positive
cells play a different role in these two joint compart-
ments, or that there is a difference in the time dynamics
of their arrival. CD3+CD4+ cells are generally regarded
as Th1 or Th2 cells producing either inflammatory or
noninflammatory network of cytokines. The investiga-
tion of Th1/Th2 cytokine profiles dominating in RA did
not confirm the classical theory of the division of cyto-
kine production. Rather, this investigation confirmed
the existence of a sequence of pathologic cell-cell inter-
actions in RA that eventually lead to the transformation
of the synovial tissue into a component of the systemic
lymphoid system17–20. There is also direct evidence that
cytolytic CD4+ cells containing intracellular protein per-
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Fig. 9. The percentages of CD25 positive lymphocytes in auto-
logous samples (PBL, SFL, SML) obtained from 30 (21 female,
9 male) acute rheumatoid arthritis patients were estimated by
flow cytometry and included in the statistical analysis (X±SE).
PBL – peripheral blood lymphocytes, SFL – synovial fluid lym-
phocytes, SML – synovial membrane lymphocytes. Level of
significance: * p0.05.
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Fig. 8. The ratios of CD16 and CD56 positive lymphocytes in the
population of peripheral blood lymphocytes (PBL), synovial fluid
lymphocytes (SFL) and synovial membrane lymphocytes (SML)
obtained from 30 (21 female, 9 male) acute rheumatoid arthritis
patients.
forin (CD4+P+) are generated in vivo in the joints of RA
patients, which suggest their involvement in the cell-
-mediated cytotoxicity operating in RA joints21.
Contrary to the results regarding the CD4+ T cell
population, the frequency of CD8+ cytotoxic T lympho-
cytes – known to constitutively express perforin mole-
cule in their cytoplasm – was higher in the synovial
fluid of acute RA patients, compared to their frequency
in peripheral blood and synovial membrane. The patho-
genic role of cytotoxic T lymphocytes in RA was empha-
sized, and previous studies revealed that this cytolytic
cell subpopulation is involved in pathological cellular
interaction21, leading to the activation of T and B lym-
phocytes, and the degradation of collagen, mediated by
synoviocytes 22,23. Their role in cartilage and bone degra-
dation could be direct or indirect. Activated cytotoxic
lymphocytes T and NK cells, were shown to secrete
serine proteases (grenzimes) and perforin, cytolytic mol-
ecules involved in cell membrane degradation24. They
could degrade type IV collagen 2 chain in basal mem-
brane, stongly inducing transendotelial migration of cir-
culating T lymphocytes and mononuclear cells of mono-
cytic/macrophage lineage, thus contributing to synovial
hyperplasia25,26. These results suggest that intense cell
infiltration in synovial tissue is a result of pronounced
migration of both CD4+ and CD8+ lymphocytes, but that
the chemotactic signals from the synovial fluid mainly
attract CD8+ cells. This chemoattractive role is mainly
attributed to IL-6, a well-known proliferative stimulus
for CD8+ cells, predominantly detected in SF of RA
patients27. These results were followed by changes in
the CD4/CD8 ratio, which was decreased in SF, but in-
creased in SM, compared to PB. The predilection of
CD4+ cells for the synovial membrane, and of CD8+ cells
for the synovial fluid is not yet understood.
Despite many controversial results regarding the
frequency and the role of T lymphocytes in RA, there is
considerable agreement regarding the activation state
of inflamed joint tissue lymphocytes. A number of phe-
notypic and functional studies putatively demonstrated
a substantial expression of the early activation antigen
CD69, the late activation antigen HLA-DR, the trans-
ferrin receptor, but without an augmentation in the IL-2
receptor (CD25)28–32. These phenotypic changes are cha-
racteristic neither for naive, nor for the cells activated
by classical pathways. Our results regarding the activa-
tion status of lymphatic cells confirmed the low level of
IL-2R expression on peripheral blood cells, as well as on
the synovial membrane and the synovial fluid cells in
acute RA patients. Since it is known that IL-2R can dis-
appear from the surface of activated cells33, it was pro-
posed that lymphocytes in RA are in the state of late ac-
tivation. The low expression of IL-2R on RA lympho-
cytes could also be the result of a long-lasting in vivo
stimulation of lymphocytes in RA. However, in spite of a
certain degree of activation, only T lymphocytes in close
contact with the dendritic cells in the transient zone of
subintima showed characteristics of blastic transforma-
tion, and the lymphocytes isolated from other synovial
layers had minimal cytoplasmic changes and resembled
unstimulated cells34. Moreover, the suboptimal proli-
ferative response of the synovial membrane lympho-
cytes revealed upon mitogen-, anti-CD3- or cytokine-
stimulation, could be explained by the abundance of
suppressive factors in the joints of RA patients (for ex-
ample TGF?, transforming factor beta)35–38. A prelimi-
nary immunophenotypic study in RA patients, using
double staining methods, has revealed a decreased fre-
quency of the CD4+CD25+ cell population, known to be T
regulatory cells (not shown). In addition to their impor-
tant role in clonal deletion and anergy, T regulatory
cells are also essential for the down regulation of T cell
responses to both foreign and self antigens, and for the
prevention of autoimmunity39–41.
Furthermore, with the intention of explaining the
role of NK cells in the pathogenic mechanism in RA, we
analysed the frequency of cells that display NK cell an-
tigens CD16 and CD56. The results were interesting, as
the percentage of CD3–CD56+ cells was not significantly
different on local and systemic levels, and the signifi-
cantly lower percentage of CD3–CD16+ cells in the syno-
vial fluid implied the presence of a CD16–CD56+ NK cell
subpopulation.
The results of previous studies regarding cytotoxic
cells in peripheral blood, synovial fluid and membrane
of RA patients are controversial. Studies of morphologic
and functional characteristics of NK cells tested for both
types of characteristics revealed a difference in either
the number or the cytotoxic ability of NK cells16,42. This
can be explained not only by the differences in therapeu-
tic procedures used on RA patients, but also by the func-
tional sensitivity of cytotoxic tests used in different
groups of patients43. In addition, there is substantional
heterogeneity in the expression of surface NK cell anti-
gens. Furthermore, it is known that certain conven-
tional surface NK cell markers can disappear from the
cell surface upon activation. Combe et al. observed a de-
crease in NK activity in peripheral blood, synovial fluid
and synovial membrane in RA patients, disproportional
to disease intensity42. Reinitz et al., however, observed
an elevation in NK cell cytotoxic activity in the synovial
tissue, in comparison to that in autologous peripheral
blood43. Hendrich et al. also observed a decrease in the
frequency and density of CD16 marker on the surface of
synovial fluid lymphocytes, as well as a decrease in
cytotoxicity and ADCC (antibody dependent cell cyto-
toxicity). This can be explained by the presence of the
rheuma factor (RF), since it is known that the RF of IgG
isotype in a population of peripheral blood lymphocytes
from healthy donors can modulate the expression of the
CD16 molecule on the cell surface, decrease NK activity
and ADCC ability, and induce transcription and produc-
tion of IFN and TNF44.
A diminished number of NK cells, even lower than
1% of mononuclear cells in synovial tissue of rheumatic
patients, were reported by many authors42–46. These re-
sults concord with our results regarding NK cells on the
local level, especially in the synovial fluid, suggesting
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that chronic lymphoid stimulation is potentially present
in rheumatic joints as a result of the functional disabil-
ity of NK cells. However, it is known that NK cells can
decrease immune responses, such as immunoglobulin
production or autologous mixed reaction (AMLR), hen-
ce, it is possible that the lower frequency of NK cells is
responsible for the pathogenic immune processes in-
volved in RA45.
Moller et al. divided NK cells into two groups, based
on the expression of CD16 and CD56 surface molecules.
In decidua, the prevalence of CD16–/dim+ CD56+CD3–
phenotype was detected, such as in the normal colon
and some malignancies46. CD16–/dim+ NK cells have
shown various spectra of cytotoxic abilities when exam-
ined on K562 and JAR target cells, compared to bright
CD16 positive cells. The observed higher frequency of
CD56 positive cells compared to the frequency of CD16
positive cells in all examined groups suggests the pres-
ence of CD16–CD56+ cells in RA, and in OA (not shown).
We observed that the frequency of CD16–CD56+ cells
was lowest in peripheral blood, similar to the findings of
Moller et al.46, who demonstrated that more than 90% of
NK cells in peripheral blood have the CD16+CD56+CD3–
phenotype. A possible explanation for the diminuition in
the CD16 expression can be found in specific cytokine
network in RA joints, or in the fact that this type of cells
selectively infiltrates the joints of RA patients, and be-
cause their inadequate cytotoxic abilities contribute to
the progression of the disease.
In conclusion, a significantly different lymphocyte
distribution was observed on local and systemic levels
in the same group of acute RA patients. This observed
specificity of local immune responses occurring in the
synovial membrane and the synovial fluid suggests that
lymphocytes play a crucial pathogenic role in the initial
stages of rheumatoid arthritis, and confirms the hy-
pothesis of T-lymphocyte involvement in RA pathoge-
nesis.
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USPOREDBA ZASTUPLJENOSTI LIMFOCITNIH SUBPOPULACIJA ISTODOBNO NA LOKALNOJ
I SISTEMSKOJ RAZINI U BOLESNIKA S AKUTNIM REUMATOIDNIM ARTRITISOM
S A @ E T A K
Reumatoidni artritis (RA) je jedna od najte`ih upalnih i autoimunih destruktivnih bolesti zglobova, koja je ~esto
pra}ena nizom vanzglobnih poreme}aja. Patofiziolo{ki mehanizam i va`nost pojedinih stani~nih subpopulacija u po-
kretanju i odr`avanju sinovitisa jo{ nisu posve razja{njeni. U ovom smo radu, metodom proto~ne citometrije, isto-
vremeno odre|ivali zastupljenost pojedinih limfocitnih subpopulacija u sinovijalnoj teku}ini (ST), sinovijalnoj mem-
brani (SM) i perifernoj krvi (PK) bolesnika u akutnom stadiju reumatoidnog artritisa. Promjene zastupljenosti T
limfocitnih subpopulacija bile su zna~ajne na lokalnoj razini u akutnih RA bolesnika, {to je imalo za posljedicu sma-
njenje CD4/CD8 omjera u ST, a pove}anje u SM u usporedbi sa vrijednostima omjera u PK. Opa`ene razlike u zastup-
ljenosti stanica koje nose NK stani~ne biljege ukazale su na mogu}u ulogu CD16–CD56+ NK stani~ne populacije u ST.
Zna~ajne razlike u zastupljenosti pojedinih limfocitnih subpopulacija ukazuju na va`nost lokalnih imunolo{kih zbi-
vanja u SM i ST u akutnih RA bolesnika te potvr|uju zna~enje T-limfocitne hipoteze u po~etnim patogenetskim
doga|ajima u RA.
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